mTOR signaling in disease

作者:Dazert Eva*; Hall Michael N
来源:Current Opinion in Cell Biology, 2011, 23(6): 744-755.
DOI:10.1016/j.ceb.2011.09.003

摘要

The target of rapamycin (TOR) is a highly conserved serine/threonine kinase and a central controller of cell growth, metabolism and aging. Mammalian TOR (mTOR) is activated in response to nutrients, growth factors and cellular energy. Dysregulated mTOR signaling has been implicated in major disease. Here we review recent findings on the role of mTOR in cancer, metabolic disorders, neurological diseases, and inflammation.

  • 出版日期2011-12